CAS 220519-07-3

ABT 925 Fumarate

Produit contrôlé

CAS : 220519-07-3

Applications ABT 925 Fumerate is a dopamine D3 receptor antagonist that is used in the treatment of acute schizophrenia (1).
References (1) Redden, L., et al.: J. Clin. Psychopharmacol, 31, 221 (2011)

Formule : C₂₄H₃₁F₃N₆O₅S

Couleur et forme : Neat

Masse moléculaire : 572.6

Ref: TR-A112600

ABT 925-d6 fumerate

CAS : 220519-07-3

ABT 925-d6 fumerate is a deuterated chemical compound, which serves as a stable isotope-labeled reagent. It is synthesized through the substitution of hydrogen atoms with deuterium in the fumerate moiety, offering increased stability for analytical applications. The incorporation of deuterium enhances the compound's resistance to metabolic degradation and allows for precise tracking in biological systems via mass spectrometry.

Formule : C₂₄H₃₁F₃N₆O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 572.6 g/mol

Ref: 3D-VIA51907

ABT-925 fumarate

CAS : 220519-07-3

ABT-925/A-37203 is a selective DRD3 antagonist, with ~100x more affinity for D₃ over D₂, tested in schizophrenia.

Formule : C₂₄H₃₁F₃N₆O₅S

Couleur et forme : Solid

Masse moléculaire : 572.6

Ref: TM-T69808